BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38278716)

  • 21. The severe clinical phenotype for a heterozygous Fabry female patient correlates to the methylation of non-mutated allele associated with chromosome 10q26 deletion syndrome.
    Hossain MA; Yanagisawa H; Miyajima T; Wu C; Takamura A; Akiyama K; Itagaki R; Eto K; Iwamoto T; Yokoi T; Kurosawa K; Numabe H; Eto Y
    Mol Genet Metab; 2017 Mar; 120(3):173-179. PubMed ID: 28087245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
    Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
    Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic
    Doheny D; Srinivasan R; Pagant S; Chen B; Yasuda M; Desnick RJ
    J Med Genet; 2018 Apr; 55(4):261-268. PubMed ID: 29330335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pitfalls of X-chromosome inactivation testing in females with Fabry disease.
    Řeboun M; Sikora J; Magner M; Wiederlechnerová H; Černá A; Poupětová H; Štorkánova G; Mušálková D; Dostálová G; Goláň L; Linhart A; Dvořáková L
    Am J Med Genet A; 2022 Jul; 188(7):1979-1989. PubMed ID: 35338595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
    Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
    Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.
    Chong Y; Kim M; Koh ES; Shin SJ; Kim HS; Chung S
    BMC Med Genet; 2016 Oct; 17(1):76. PubMed ID: 27776503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLA variation p.E66Q identified as the genetic etiology of Fabry disease using exome sequencing.
    Peng H; Xu X; Zhang L; Zhang X; Peng H; Zheng Y; Luo S; Guo H; Xia K; Li J; Yao H; Hu Z
    Gene; 2016 Jan; 575(2 Pt 1):363-7. PubMed ID: 26456105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease.
    Choi JS; Kim CS; Park JW; Bae EH; Ma SK; Choi YD; Kim GH; Yoo HW; Kim SW
    Ren Fail; 2012; 34(3):390-3. PubMed ID: 22260214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Overview of Molecular Mechanisms in Fabry Disease.
    Amodio F; Caiazza M; Monda E; Rubino M; Capodicasa L; Chiosi F; Simonelli V; Dongiglio F; Fimiani F; Pepe N; Chimenti C; Calabrò P; Limongelli G
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is it Fabry disease?
    Schiffmann R; Fuller M; Clarke LA; Aerts JM
    Genet Med; 2016 Dec; 18(12):1181-1185. PubMed ID: 27195818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The heart in Fabry's disease.
    Sheppard MN
    Cardiovasc Pathol; 2011; 20(1):8-14. PubMed ID: 19919901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabry disease: GLA deletion alters a canonical splice site in a family with neuropsychiatric manifestations.
    Varela P; Carvalho G; Martin RP; Pesquero JB
    Metab Brain Dis; 2021 Feb; 36(2):265-272. PubMed ID: 33156427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.
    Ferreira S; Ortiz A; Germain DP; Viana-Baptista M; Caldeira-Gomes A; Camprecios M; Fenollar-Cortés M; Gallegos-Villalobos Á; Garcia D; García-Robles JA; Egido J; Gutiérrez-Rivas E; Herrero JA; Mas S; Oancea R; Péres P; Salazar-Martín LM; Solera-Garcia J; Alves H; Garman SC; Oliveira JP
    Mol Genet Metab; 2015 Feb; 114(2):248-58. PubMed ID: 25468652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
    Duro G; Zizzo C; Cammarata G; Burlina A; Burlina A; Polo G; Scalia S; Oliveri R; Sciarrino S; Francofonte D; Alessandro R; Pisani A; Palladino G; Napoletano R; Tenuta M; Masarone D; Limongelli G; Riccio E; Frustaci A; Chimenti C; Ferri C; Pieruzzi F; Pieroni M; Spada M; Castana C; Caserta M; Monte I; Rodolico MS; Feriozzi S; Battaglia Y; Amico L; Losi MA; Autore C; Lombardi M; Zoccali C; Testa A; Postorino M; Mignani R; Zachara E; Giordano A; Colomba P
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney involvement in Anderson-Fabry disease.
    Meroni M; Sessa A; Battini G; Tazzari S; Torri Tarelli L
    Contrib Nephrol; 1997; 122():178-84. PubMed ID: 9399062
    [No Abstract]   [Full Text] [Related]  

  • 37. Functional evaluation of a novel GLA causative mutation in Fabry disease.
    Li P; Zhang L; Xiong Q; Wang Z; Cui X; Zhou YA; Wang Y; Xiao H; Wu C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e864. PubMed ID: 31321922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between GLA variants and alpha-Galactosidase A profile in dried blood spot: an observational study in Brazilian patients.
    Varela P; Mastroianni Kirsztajn G; Motta FL; Martin RP; Turaça LT; Ferrer HLF; Gomes CP; Nicolicht P; Mara Marins M; Pessoa JG; Braga MC; D'Almeida V; Martins AM; Pesquero JB
    Orphanet J Rare Dis; 2020 Jan; 15(1):30. PubMed ID: 31996269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease.
    Germain DP; Levade T; Hachulla E; Knebelmann B; Lacombe D; Seguin VL; Nguyen K; Noël E; Rabès JP
    Clin Genet; 2022 Apr; 101(4):390-402. PubMed ID: 34927718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene.
    Redonnet-Vernhet I; Ploos van Amstel JK; Jansen RP; Wevers RA; Salvayre R; Levade T
    J Med Genet; 1996 Aug; 33(8):682-8. PubMed ID: 8863162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.